Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Clinical trial NCT01234012 · COMPLETED
Trial details
- NCT number
- NCT01234012
- Sponsor
- ImmunoFrontier, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.